The Effect of Asset Efficiency on Stock Return with the Moderating Role of Financial Flexibility in Pharmaceutical Companies Listed on the Tehran Stock Exchange

The Effect of Asset Efficiency on Stock Return with the Moderating Role of Financial Flexibility in Pharmaceutical Companies Listed on the Tehran Stock Exchange

Fatemeh Zarin1 Reza Khoshsima2 Shahla Torkani3

1) 1. Department of Accounting, Islamshahr Branch, Islamic Azad University, Islamshahr, Iran.
2) 2. Department of Economics, Islamshahr Branch, Islamic Azad University, Islamshahr, Iran.
3) 3. Department of Accounting, West Tehran Branch, Islamic Azad University,Tehran, Iran.

IOI Code : ABFK-ACZZBB
Publication : The third international conference on new researches in management, law, humanities and entrepreneurship(icmlhe.ir)
Abstract :
    Stock return is one of the most important indicators of corporate performance and a key criterion for investors’ decision-making in capital markets. Identifying the factors affecting stock returns can contribute to improving managerial and investment decisions. This study aims to examine the effects of asset efficiency on stock returns, with emphasis on the moderating role of financial flexibility, in pharmaceutical companies listed on the Tehran Stock Exchange. The study is applied in terms of purpose and descriptive-correlational in terms of research method, employing a panel-data approach. The statistical population consists of pharmaceutical companies listed on the Tehran Stock Exchange during the study period, and the required data were collected from companies’ financial statements, financial reports, and market information. In this study, asset efficiency is considered independent variables, stock return is the dependent variable, and financial flexibility is the moderating variable. Financial leverage and firm size are also included as control variables. The hypotheses were tested using appropriate econometric and panel-data regression methods. The results indicate that asset efficiency has a positive and significant effect on stock returns. Furthermore, financial flexibility positively and significantly moderates the relationships between asset efficiency and stock returns. These findings suggest that pharmaceutical companies with greater efficiency in utilizing their assets and operational resources, combined with higher financial flexibility, have greater potential to generate higher stock returns and can provide useful implications for corporate managers, investors, and financial analysts in evaluating corporate performance and making financial and investment decisions.

Keywords : asset efficiency stock return financial flexibility pharmaceutical companies tehran stock exchange